Toward a Recognition of Key Role players in Community Pharmacy Key Role Players in Community Pharmacy
International Pharmacy Acta,
Vol. 6 No. 1 (2023),
29 Bahman 2023
,
Page e2: 1-8
https://doi.org/10.22037/ipa.v6i1.38870
Abstract
Although private community pharmacies are identified as health care facilities, they are highly affected by business management issues. As an example of public-private partnership in the health sector, private community pharmacies have multiple key stakeholders. This study is a comprehensive stakeholder analysis which aims to identify, classify, and analyze multiple key stakeholders involved in the community pharmacy business and their interests, relationship, and behavior. This understanding of the context and evaluation of the above factors will help community pharmacy managers develop suitable strategies to properly manage the stakeholders in order to better achieve organizational goals. A focus group was conducted with key informants. The first phase of the focus group identified stakeholders through brainstorming techniques. In the second phase, stakeholder analysis and classification were performed using a three-dimensional matrix. Identified stakeholders were differentiated by levels of relationship with community pharmacies. They were analyzed regarding three attributes of power, legitimacy, and urgency, and were grouped into eight classes including definitive, dormant, dominant, discretionary, dependent, demanding, and dangerous stakeholders and non-stakeholders. The results of the focus group were converted to a structured questionnaire and confirmed in several face-to-face interviews until reaching a consensus. Four main levels of relationship and eight categories of stakeholders were identified by qualitative analysis through conducting a focus group with key informants. The core stakeholders include pharmacy licensee, licensee-owner, responsible pharmacist, customer, prescriber, health insurance, regulatory body, and staff. The core stakeholders possess three saliences of power, legitimacy, and urgency. Therefore, they are directly involved in decision making. Further deliberations are necessary to analyze the behavior of stakeholders and investigate the communication model.
- Community Pharmacy
- Focus Groups
- Stakeholder Matrix
- Health Policy
- Pharmacy Administration
How to Cite
References
Bennett J, Iossa E. Delegation of contracting in the private provision of public services. Rev Ind Organ. 2006;29:75–92.
Jofre-Bonet M. Health care: private and/or public provision. Eur J Polit Econ. 2000;16:469–489.
Culyer AJ, Newhouse JP, Pauly M V, McGuire TG, Barros PP. Handbook of health economics. 1st ed. Elsevier; 2000.
Jakovljevic M. Health Economics and Policy Challenges in Global Emerging Markets. Nova Science Publishers, Incorporated; 2016.
Torchia M, Calabrò A, Morner M. Public–Private Partnerships in the Health Care Sector: A systematic review of the literature. Public Manag Rev. 2015 Feb 7;17(2):236–61. Available from: https://doi.org/10.1080/14719037.2013.792380
Brugha R, Varvasovszky Z. Stakeholder analysis: a review. Heal Policy Plann. 2000;15(3):239–246.
Mitchell RK, Agle BR, Wood DJ. Toward a theory of stakeholder identification and salience: Defining the principle of who and what really counts. Acad Manag Rev. 1997;22:853–886.
Kitzinger J. The methodology of Focus Groups: the importance of interaction between research participants. Sociol Health Illn. 1994;16(1):103–21.
Krueger RA. Focus Groups, a Practical Guide for Applied Research. Fifth. SAGE publication; Thousand Oaks, CA; 2009.
Freeman RE. Strategic management: A stakeholder approach. Adv Strateg Manag. 1983;1(1):31–60.
Blane D, Brunner E, Wilkinson R. Health and Social Organization: Towards a Health Policy for the 21st Century. Routledge, London; 1996.
Vozikis A, Stavropoulou L, Patrinos GP. Community Pharmacists¡ ̄ Strategies in Greece: An Assessment of the Policy Environment and the Mapping of Key Players. Health. 2015;7(11).
Franco-Trigo L, Hossain L, Durks D, Fam D, Inglis S, Benrimoj S, et al. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease. Res Soc Adm Pharm. 2017.
Sabater-Hernández D, Tudball J, Ferguson C, Franco-Trigo L, Hossain LN, Benrimoj SI. A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation. BMC Health Serv Res. 18:145.
Hossain LN, Tudball J, Franco-Trigo L, Durks D, Benrimoj SI, Sabater-Hernández D. A multilevel stakeholder approach for identifying the determinants of implementation of government-funded community pharmacy services at the primary care level. Res Soc Adm Pharm. 14:765–775.
Franco-Trigo L, Marqués-Sánchez P, Tudball J, Benrimoj SI, Martínez-Martínez F, Sabater-Hernández D. Collaborative health service planning: A stakeholder analysis with social network analysis to develop a community pharmacy service. Res Social Adm Pharm. 2020;16(2):216-229.
Friedman AL, Miles S. Stakeholders: Theory and Practice. OUP Oxford;
Wagner Mainardes E, Alves H, Raposo M. A model for stakeholder classification and stakeholder relationships. Manag Decis. 50:1861–1879.
McKenzie JF, Neiger BL, Smeltzer JL. Planning, Implementing, and Evaluating Health Promotion Programs: A Primer. Pearson/Benjamin Cummings; San Fransico, CA; 2005.
Bryson JM. What to do when stakeholders matter: A guide to stakeholder identification and analysis techniques. A Pap Present London Sch Econ Polit Sci. 2003;10.
de Vries J. The shaping of inventory systems in health services: A stakeholder analysis. Int J Prod Econ. 2011;133(1):60–9.
Franco-Trigo L, Hossain L, Durks D, Fam D, Inglis S, Benrimoj S, et al. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease. Res Soc Adm Pharm. 2017.
Kanavos P, Costa-i-Font J, Merkur S, Gemmill M. The economic impact of pharmaceutical parallel trade in European Union member states: A stakeholder analysis. London: LSE Health Social Care Special Research Paper. 2004.
Nikfar S, Kebriaeezadeh A, Majdzadeh R, Abdollahi M. Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran. BMC Int Heal Hum R. 5:5.
Kirchner JE, Parker LE, Bonner LM, Fickel JJ, Yano EM, Ritchie MJ. Roles of managers, frontline staff and local champions, in implementing quality improvement: stakeholders’ perspectives. J Eval Clin Pr. 18:63–69.
Poolnews. Selling several hundred million pharmacy licensees in the market [Internet]. Available from: https://www.asriran.com/fa/news/537181/
Keshavarz K, Kebriaeezadeh A, Meshkini AH, Nikfar S, Mirian I, Khoonsari H. Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business? DARU. 20:62.
Aggregation of patients with Gaucher’s disease [Internet]. Available from: https://www.isna.ir/news/95071005815
Cheraghali A, Nikfar S, Behmanesh Y, Rahimi V, Habibipour F, Tirdad R, et al. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. East Mediterr Heal J. 10:406–415.
Toroitich A, Dunford L, Armitage R, Tanna S. Patients Access to Medicines – A Critical Review of the Healthcare System in Kenya. Risk Manag Healthc Policy. 2022; 15:361–74.
Furlow B. Persistent drug shortages jeopardise patient safety in the USA. Lancet Respir Med. 2015;3(3):182–3.
Shukar S, Zahoor F, Hayat K, et al. Drug Shortage: Causes, Impact, and Mitigation Strategies. Front Pharmacol. 2021;12:693426. Published 2021 Jul 9. doi:10.3389/fphar.2021.693426
Wertheimer AI, Curtiss F, Vedder A, Lindblom J, Hydukovich D. Colleague or Competitor? A Study of Community Pharmacy Relationships. J Am Pharm Assoc. 1977;17(3):158–60.
Heinsohn JG, Flessa S. Competition in the German pharmacy market: an empirical analysis. BMC Health Serv Res. 2013;13:407. Published 2013 Oct 10. doi:10.1186/1472-6963-13-407.
Lépineux F. Stakeholder theory, society and social cohesion. Corp Gov Int J Bus Soc. 2005;5:99–110.
Mayall SJ, Banerjee AS. Therapeutic Risk Management of Medicines. Elsevier. 2014.
Rangchian M, Mehralian G, Salamzadeh J, Vatanpour H. Intra- And Extra-Organizational Factors Affecting Community Pharmacy Performance. Value Heal. 2015;18:543.
- Abstract Viewed: 93 times
- IPA-2023-Vol6-e2 Downloaded: 68 times